论文部分内容阅读
目的 比较克脂星与普伐他汀治疗高脂血症的疗效。方法 高血脂症病人 80例 ,男 38例 ,女 42例 ,年龄 (5 6± 8)岁 ,服用克脂星 2粒 (0 .5g/粒 )po ,tid ,连续 8周 ;另 40例 ,男 19例 ,女 2 1例 ,年龄 (5 5± 9)岁 ,普伐他汀片 5mg ,po ,bid连续 8周。结果 2组均能降低TC ,TG及升高HDL -CH。克脂星组分别依次下降 2 0 % ,40 %及HDL -CH升高 2 9% ;普伐他汀组下降2 0 % ,39% ,升高 2 8%。组间比较无显著差异 ,普伐他汀组有轻微不良反应。结论 克脂星与普伐他汀治疗高脂血症的疗效比较 ,前者略优于后者 ,无明显不良反应发生
Objective To compare the efficacy of gliadin and pravastatin in the treatment of hyperlipidemia. Methods Hyperlipidemia patients 80 cases, 38 males and 42 females, aged (56 ± 8) years old, taking two grams of liposide (0.5g / tablets) po, tid for 8 weeks; the other 40 cases, 19 males and 21 females, aged (55 ± 9) years, pravastatin tablets 5mg, po, bid for 8 weeks. Results Both groups decreased TC, TG and increased HDL-CH. The number of gliptin groups decreased by 20%, 40% and HDL-CH by 29%, while that in pravastatin group decreased by 20%, 39% and 28% respectively. There was no significant difference between groups, with mild adverse reactions in the pravastatin group. Conclusions The efficacy of gliadin and pravastatin in the treatment of hyperlipidemia is slightly better than the latter, with no obvious adverse reactions